Amy Crowe

Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With <i>E coli</i> or <i>Klebsiella pneumoniae</i> Bloodstream Infection and Ceftriaxone Resistance

Patrick N. A. Harris, Paul Anantharajah Tambyah, David Chien Lye et al. · JAMA · 2018 · 770 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Association Between Minimum Inhibitory Concentration, Beta-lactamase Genes and Mortality for Patients Treated With Piperacillin/Tazobactam or Meropenem From the MERINO Study

Andrew Henderson, David L. Paterson, Mark D. Chatfield et al. · Clinical Infectious Diseases · 2020 · 158 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

Whole genome analysis of cephalosporin-resistant Escherichia coli from bloodstream infections in Australia, New Zealand and Singapore: high prevalence of CMY-2 producers and ST131 carrying blaCTX-M-15 and blaCTX-M-27

Patrick N. A. Harris, Nouri L. Ben Zakour, Leah W. Roberts et al. · Journal of Antimicrobial Chemotherapy · 2017 · 82 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Predicting functional capacity during treadmill testing independent of exercise protocol

Carl Foster, Amy Crowe, E Daines et al. · Medicine & Science in Sports & Exercise · 1996 · 73 citations

Education, Kinesiology, Exercise Physiology +16

Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia

Amy Crowe, Nicole McMahon, Bart J. Currie et al. · International Journal of Antimicrobial Agents · 2014 · 60 citations

Life Sciences, Infectious Diseases, Microbiology +15